Company intelligence / Profile preview
Cann Group Limited
Melbourne, Victoria, Australiacanngrouplimited.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Leading Australian medicinal cannabis producer focused on R&D-driven B2B/B2C models
- Therapeutic areas
- OtherNeurology
- Modalities
- Plant-derived cannabinoidsOral microbead capsules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
GlaxoSmithKline Consumer Healthcare – evaluation agreement for potential commercialization of the Satipharm CBD capsule in Australia as an OTC productChemist Warehouse – new supply agreements to expand access to products through retail pharmacy outlets in QueenslandGrodan – supplier partnership supporting cultivation operations at Mildura facility
Beyond the preview
Go deeper on Cann Group Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cann Group Limited.